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ABSTRACTSResults: We identiﬁed 19 studies investigating simulation options in
robotic surgery. Eleven studies compared performance between two
different groups; Expert and Novice. Experts ranged in experience from
21-2200 robotic cases. The novice groups consisted of participants with no
prior experience on a robotic platform. The MdVT, ProMIS, SEP and Intu-
itive systems have shown face, content and construct validity. The RoSS
system has only been face and content validated. All of the simulators
except SEP have shown educational impact. Feasibility, educational impact
and cost-effectiveness of simulation systems was not evaluated by the
studies. Virtual reality simulators were demonstrated to be effective
training tools for junior trainees.
Conclusions: Simulation training holds the greatest potential to be used
as an adjunct to traditional training methods in order to equip the next
generation of robotic surgeons with the skills required to operate safely.
More research is needed to validate simulated environments and
investigate the effectiveness of animal and cadaveric training in robotic
surgery.
0337: STAGING IT BEFORE DIAGNOSING IT. A NOVEL RISK ASSESSMENT
TOOL FOR PROSTATE CANCER
Rozh Jalil 1, Nirav Patel 2, John O'Neil 2, James Green 2. 1 Imperial College,
London, UK; 2Whipps Cross University Hospital, London, UK
Introduction: A 4-6 weeks waiting lapse is necessary if staging MRI is
performed after TRUS-Prostate biopsy due to the challenging interpreta-
tion of MRI because of the haemorrhage and swelling. To improve treat-
ment times, we discuss a novel idea of identifying patients who would
beneﬁt most from a staging-type MRI before TRUS-P biopsy using a simple
risk assessment tool.
Materials and Methods: A retrospective study enrolled 503 patients who
were referred to our hospital on the 2 week wait prostate pathway. After
analysing data from these patients, a tool was developed primarily using
age and PSA. Ages 60-80 (grouped into 60-64, 65-69, 70-74 and 75-79)
were included due to the feasibility of radical treatment. Each group was
allocated a speciﬁc PSA range in an attempt to render most possible cancer
patients who had MRI.
Results: The application of this tool identiﬁed a subgroup of patients aged
60-79 (n¼124) with MRI rates of 48.4% and a cancer rate of 57.3%. These
comprised 43.3 % of all cancers in this age group 60-79.
Conclusions: Applying this tool will identify patients that can beneﬁt from
upfront staging MRI and hence early commencement of deﬁnitive treat-
ment. Subsequently the cancer target wait is easier to achieve.
0346: NEWLY DIAGNOSED PROSTATE CANCER: ARE MEN BEING
REFERRED SAFELY AND APPROPRIATELY FROM PRIMARY CARE?
M. Fullarton, T. Balling, N.I. Osman, B.A. Petersson, C.S. Powell. Countess of
Chester Hospital, Chester, UK
Aim: Many GPs ﬁnd prostate cancer (CaP) diagnosis difﬁcult. Although
referral guidelines are available, anecdotal evidence suggests a disparity in
approach between GPs and urologists. We determined whether men with
histological CaP were referred appropriately from primary care.
Methods: We conducted a retrospective case-note review of 77 consecu-
tive patients undergoing Trans-rectal prostate biopsies after 1st outpatient
visit. Type, reason and quality of referral were determined.
Results: 77 men underwent biopsies with a mean-age of 71.1. 27.3% were
routine referrals, 13% urgent and 59.7% 2-week rule. 5 patients had no PSA
testing pre-referral, 42 had 1, 26 had 2 and 4 had >2. 90.3% were referred
with a raised PSA. 67.5 % had rectal examinations (RE) pre-referral. 31.2%
patients had urinalysis pre-referral. 64.9% had histological CaP, 1.3% PIN,
33.8% benign histology (1 patient failed to attend biopsy). 72% of those
with histological CaP were referred by 2 week-rule, 70% of whom had RE.
Conclusions: Most patients with suspected or proven CaP were referred
under 2-week rule. Although quality of referral varied, most were appro-
priate. Areas for improvement include performance of RE and urinalysis.
To avoid delays in diagnosis, education is needed to bring the practices of
GPs and urologists in concordance.
0353 WINNER OF ASIT-SURG PRIZE: CONTEMPORARY OCCUPATIONAL
BLADDER CANCER: A SYSTEMATIC REVIEW OF CURRENT EXPOSURES
Marcus Cumberbatch, James Catto, Simon Pickvance. University of
Shefﬁeld, Shefﬁeld, UKBackground: Bladder cancer is a common disease that often arises
following occupational exposure to carcinogens. Improved workplace
hygiene and industrial sanctions have controlled or substituted the use of
known bladder carcinogens. However, between 5 and 25% of contempo-
rary tumours still arise following workplace carcinogen exposure, sug-
gesting either unknown or uncontrolled exposure is still common.
Aim: To systematically review recent evidence (since 1990) for occupa-
tional bladder cancer and to identify contemporary occupations implicated
in its aetiology.
Method: A systematic review using Pubmed with strings to search for
occupation and bladder cancer was conducted using limits to control for
study design and select contemporary studies. After review using strict
exclusion criteria, and following reference checks, 87 studies were
included for analysis.
Results: Contemporary at risk occupations include: agricultural
workers, drivers, engineers, ﬁre-ﬁghters, laundry workers, metal and
metal-ﬂuid workers, miners, nurses, plastics workers, pharmaceutical
workers, print workers, textile workers, tool-makers, waiters, and wood
workers.
Conclusion:Many of these are modern additions to our database of at risk
occupations to bladder cancer and alterations in disease demographics
suggest a variety of possible carcinogens requiring investigation. Occupa-
tional exposure remains an important public health problem that should
be understood and incorporated into patient management.
0370: DOES OPERATOR EXPERIENCE AFFECT THE OUTCOME OF
TRANSRECTAL PROSTATE BIOPSY?
Adam Hussein, Sergey Tadtayev, Gregory Boustead. Lister Hospital,
Stevenage, UK
Cancer detection rate (CDR) is the single most important outcomemeasure
of transrectal ultrasound-guided (TRUS) prostate biopsies. It is established
that a number of factors inﬂuence outcome of the biopsy, but there is
a paucity of data on the effect of operator experience.
We conducted a retrospective review of 344 patients who underwent their
ﬁrst TRUS biopsy in a single institution over a 12 month period. Biopsies
were undertaken by 6 consultants (103). 8 senior trainees parcticing TRUS
for>1year (139) and 3 junior trainees who just started TRUS training (102).
Fisher's test was used for statistical analysis.
There was a signiﬁcant difference in the CDR between consultants and
juniors (p<0.005), and senior and junior trainees (p¼0.008) at the expense
of more Gleason 6 cancer found in the ﬁrst vs third group (p¼0.03). We
could not identify evidence of a learning curve amongst juniors.
We have demonstrated higher CDR by more experienced TRUS operators,
likely due to superior sampling. This ﬁnding implies that mentoring, self-
audit and close follow-up are essential. The TRUS learning curve is likely to
exceed 30 cases. CDR in our study is similar to values published in
comparable cohorts (30-40%).
0481: IMPROVED FIVE YEAR SURVIVAL ESTIMATES OF RADICAL
CYSTECTOMIES PERFORMED AT A HIGH VOLUME DISTRICT GENERAL
HOSPITAL
Robert Pallas, James Osborne, James Wilson, Adam Carter. Royal Gwent
Hospital, Newport, UK
Radical cystectomy is a major operation with signiﬁcant complications.
There has been suggestion of centralising this operation to high volume
cancer centres. All cystectomies for cancer performed at our centre
between 2000 and 2010 were retrospectively analysed for survival data.
Results were compared to published data from gold standard insitutions.
A total of 160 cystectomies were performed by six surgeons, an average of
12 per year between 2000 and 2006, and 18 per year since 2007. Data was
gathered from theatre database operation codes and correlated with
follow up data from electronic hospital records. Survival was estimated
using Kaplan-Meier estimation, and sub-divided based on T-grading.
Results of cystectomies performed prior to 2007 were compared to
subsequent operations.
There is a statistically signiﬁcant difference between 5 year survival of T1/
T2 and T3/4 patients. Cases performed between 2000-2006 had a 5-year
survival rate of 45%, this improved to 57% in patients operated 2007-2010.
The 5-year survival and 30 day mortality ﬁgures are comparable to
publications frommajor institutions. Recent cystectomies have improved 5
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ABSTRACTSyear survival estimates, but follow up limits comparison of actual survival.
However, a recent study has suggested that 2 year follow up data corre-
lates well with 5-year survival.
0486: "SATURATION PROSTATE BIOPSY IN PATIENTS WITH RAISED AGE-
RELATED PSA AND NON-MALIGNANT PREVIOUS TRUS BIOPSIES"
Michelle Christodoulidou, Mohsen El-Gammal. Southport and Ormskirk
Hospital NHS Trust, Southport,Merseyside, UK
Aim: To review the demographic data of patients that underwent Satu-
ration Prostate Biopsies over an 18 month period with emphasis on the
indications, antibiotic cover, complications and histological outcome.
Method: Patients were traced by the Theatres Register and GALAXY
system. Data were collected from case notes.
Results: 28 Saturation Biopsies were performed between July 2010 and
December 2011. Median age was 67, 54% of patients had LUTS and 7% had
family history of prostate cancer. 14% had abnormal DRE. Median value of 2
TRUS biopsies were taken prior to the Saturation Biopsy. All patients were
given 160mg Gentamicin IV and a 3 day course of Ciproﬂoxacin orally. Only
one case presentedwith Urosepsis requiring IV antibiotics. Saturation biopsy
diagnosedmalignancy in36%ofpatients.1patientwhohadbenign saturation
biopsy subsequently underwent a Template biopsy that showedmalignancy.
Conclusions: Saturation Biopsy is useful in diagnosing prostate cancer in
about 36% of cases after 2 inconclusive TRUS Biopsies. The pick up rate of
cancer is higher than a 3rd TRUS biopsy. The currently adopted antibiotic
prophylaxis appears appropriate with 3.6% risk of urosepsis. When Satu-
ration Biopsy is non malignant and PSA is still rising, template biopsy
maybe considered.
0524: USE OF THE SWOP CALCULATOR TO REDUCE UNNECESSARY
PROSTATE BIOPSIES IN MEN WITH ELEVATED PSA
Andrew Birch 1, John Withington 1, Janette Kinsella 2, Peter Acher 1, Ben
Challacombe 2. 1 East Sussex Healthcare NHS Trust, East Sussex, UK; 2Guy's
and St. Thomas' NHS Foundation Trust, London, UK
Background: The SWOP calculator is a nomogram derived from the Euro-
pean Randomised Study of Screening for Prostate Cancer which predicts the
percentage probability ofmalignant prostate biopsy by using the variables of
age, DRE ﬁnding, PSA, ultrasound appearance and prostate volume.
Aim: To investigate whether using a 10% or 15% risk threshold could avert
unnecessary biopsies.
Method: Data from 207 eligible patients (median age 60) biopsied from
2004-2010 were entered retrospectively into the risk calculator. The clin-
ical outcomes for patients with 15% SWOP risk were investigated.
Results: Of the 42 patients with 15% SWOP risk 13 patients (31%) had
malignant histology at biopsy (9 Gleason 3+3, 4 Gleason 3+4), 7 received
radical treatment (5 radical prostatectomies, 2 brachytherapy) and 5
entered active surveillance.
Of the 17 patients with a SWOP risk 10% 4 (24%) had positive biopsies
(Gleason 3+3); none required treatment, 3 entered active surveillance (one
patient has no follow-up data).
Conclusions: These data show that were a 15% risk threshold applied, then
signiﬁcant prostate cancers requiring treatment would have been missed
but a 10% risk-threshold may have avoided unnecessary biopsies.
The SWOP calculator may be useful for avoiding unnecessary biopsies in
low-risk patients; this has signiﬁcant implications for reducing biopsy and
treatment morbidity and cost.
0551: TRANSPERINEAL TEMPLATE-GUIDED SATURATION BIOPSIES OF
THE PROSTATE – EARLY EXPERIENCES IN A DISTRICT GENERAL
HOSPITAL OF A NOVEL TECHNIQUE OF SATURATION BIOPSY
Jaspal Phull, Alison Townsend, Megan Whitaker, Llinos Davies, Andy
Thomas. Princess of Wales Hospital, Bridgend, UK
Aims: Transrectal ultrasound-guided (TRUS) biopsy may miss 30% of
signiﬁcant prostate cancer, likely to be in the anterior zone. Transperineal
template-guided saturation biopsies (TTB) is a NICE approved means of
saturation-biopsy. We assessed detection rates with TTB.
Methods: A prospective, non-randomized, cohort study of TTBs between
July 2010 and August 2011. All cases were peer-reviewed at MDT, and
would seek radical treatment if positive.
The primary outcome was detection of malignancy.Results: 22 TTBs were performed. 81.8% (n¼18) had >1 negative TRUS, 9.1%
(n¼2) were on active surveillance, 4.5% (n¼1) was post-radiotherapy PSA-
relapse, and 4.5% (n¼1) chose to have TTB as the primary biopsy method.
12 of the 22 cases (54.5%) had new-diagnosis carcinoma only detected at
TTB. 7 were benign (31.8%).
Of the malignant histology (n¼15) 13.3% were Gleason 6 (n¼2), 73.3% were
Gleason 7 (n¼11), and 13.3% were Gleason 8 carcinomas (n¼2).
Conclusion: TTB should be considered for men with rising PSAs and
negative TRUS biopsy. We advocate TTB as the preferred technique for
saturation biopsy for detection of signiﬁcant prostate cancer in men who
would beneﬁt from further treatment.
0572: OUT-PATIENT FLEXIBLE CYSTOSCOPY CAUSES PSYCHOLOGICAL
DISTRESS TO A SIGNIFICANT NUMBER OF PATIENTS BEING
INVESTIGATED FOR BLADDER CANCER
Gidon Ellis 1, Jamie Fairweather 1, Ninaad Awsare 2, Sam Osaghae 3, Sam
Smith 4, Thomas McNicholas 5, James Green 1. 1Whipps Cross University
Hosptial, London, UK; 2Morriston Hospital, Swansea, UK; 3 Pilgrim Hospital,
Lincolnshire, UK; 4University College London, London, UK; 5 Lister Hospital,
Stevenage, UK
Introduction: Many patients undergoing outpatient ﬂexible cystoscopy
experience psychological distress. This may relate to the impending
procedure and to the possibility of discovering cancer. We set out to
investigate the prevalence of signiﬁcant psychological distress in a cohort
of patients undergoing ﬂexible cystoscopy and to identify subsets of the
population who may be at higher risk.
Methods: We recruited 173 patients undergoing out-patient ﬂexible
cystoscopywho completed questionnaires containing the Hospital Anxiety
and Depression Score-A (HADS) and HADS-D to assess anxiety and
depression respectively. A score of 11/21 on either scale was regarded as
clinically signiﬁcant.
Results: The overall prevalence of anxiety was 15%, which was higher in
females (p¼0.025), in the young (p¼0.001) and in unmarried individuals
(p¼ 0.02). The prevalence of depressionwas 3.5%, which was higher in the
young (0.001) and in unmarried individuals (p¼0.02).
Conclusion: The prevalence of clinically signiﬁcant anxiety and depression
in this cohort is notable; in particular amongst women, younger and
unmarried patients. Accelerating the diagnostic pathway, improving
patient information and offering counselling to those affected may help to
reduce distress. Resources could be targeted at the higher risk groups
identiﬁed here. The HADS questionnaires are a useful ﬁrst-line screening
tool for psychological distress.
0605: SMALL SIZE NEPHROSTOMY TUBE USE POST PCNL
Ben Rossi, Michal Sut, Asheesh Kaul, Abdul Rahim Khan, Aasem
Chaudry. Bedford Hospital NHS Trust, Bedford, UK
Objective: To assess safety and outcomes of a small size 8F/8.5F neph-
rostomy tube use following Percutaneous Nephrolithotomy.
Materials and methods: Retrospective data collection from 15 PCNL cases
performed in Bedford Hospital NHS Trust over a period of 10months. Stone
clearance, hospital stay, complication rate, hemoglobin drop, analgesia and
transfusion requirements were reviewed. Data was compared to recently
published outcomes for tubeless PCNL and large bore nephrostomy use.
Results: Median hemoglobin drop was 1.3 g.dL and length of stay was 72
hours. Those were comparable to previously reported results for tubeless
PCNLand large borenephrostomy tubeuse. Complication ratewas lowat 13%
with only one patient requiring admission and treatment for urinary sepsis
and one patient requiring repeat procedure due to pain related to residual
stone. Stone clearance on day 1was 60%. Average analgesia requirementwas
1050mg of tramadol which was signiﬁcantly higher than in previously re-
ported studies and was likely related to our prescribing protocol.
Conclusions: Small size nephrostomy PCNL is a safe procedure with
acceptable Hb drop and length of stay. Decreased analgesia requirements
proven previously were not reproduced in our group of patients.
0622: UROLOGY CANCER PATIENTS' VIEWS ON MULTIDISCIPLINARY
TEAM (MDT) WORKING. A PILOT STUDY
Benjamin Lamb 1, Rozh Jalil 1, Sujay Shah 1, James Green 2, Paula
Allchorne 2, Nick Sevdalis 1. 1 Imperial College, London, UK; 2Whipps Cross
University Hospital, London, UK
